203724

Millipore

Brij® 35 Detergent, 30% Aqueous Solution

Non-ionic detergent useful for the isolation of functional membrane complexes. Aggregation number: 40; HLB number: 16.9. Note: product liquifies upon warming to 50°C.

Synonym(s):
Polyoxyethyleneglycol Dodecyl Ether, Polyoxyethylene (23) Lauryl Ether
CAS Number:

storage conditions

+15C to +30C

Quality Level

form

gel form

manufacturer/tradename

Calbiochem®

storage condition

OK to freeze

aggregation number

40

color

clear

CMC

92 μM

shipped in

ambient

storage temp.

15-25°C

InChI

1S/C14H30O2/c1-2-3-4-5-6-7-8-9-10-11-13-16-14-12-15/h15H,2-14H2,1H3

InChI key

SFNALCNOMXIBKG-UHFFFAOYSA-N

General description

Non-ionic detergent useful for the isolation of functional membrane complexes. Aggregation number: 40; HLB number: 16.9.
Note: product liquifies upon warming to 50°C.
Non-ionic detergent useful for the isolation of functional membrane complexes (aggregation number: 40; CMC: 92 mM; HLB number: 6.9). Product liquefies upon warming to 50°C.

Packaging

100 ml in poly bottle
1 l in Glass bottle

Warning

Toxicity: Harmful (C)

Physical form

30% aqueous solution.

Legal Information

Brij is a registered trademark of Croda International PLC
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Pictograms

Corrosion

Signal Word

Danger

Hazard Statements

Precautionary Statements

WGK Germany

WGK 2

Certificate of Analysis
Certificate of Origin
Protocols
This page shows how to solubilize membrane proteins with products from Cytiva.
Read More

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.